STAMPEDE2 Trial: a Survey on National Variations in Access to Novel Imaging in Metastatic Prostate Cancer and Implications for Trial Conduct

Purpose: The forthcoming STAMPEDE2 trial has three comparisons in metastatic hormone-sensitive prostate cancer (mHSPC). We aim to determine clinical practices across current trial sites in relation to imaging.

Source: Clinical Oncology - December 21, 2023 Category: Radiology Authors: H. Abdel-Aty, L. O ’Shea, C. Amos, L.C. Brown, E. Grist, G. Attard Source Type: research